Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Qing Wang

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Molecular Therapy. Nucleic Acids|March 13, 2019
Knockdown of IGF-1R Triggers Viral RNA Sensor MDA5- and RIG-I-Mediated Mitochondrial Apoptosis in Colonic Cancer CellsShu-Qing Wang, Xiang-Yu Yang, Xin-Feng Yu, et al.
Free Radical Biology & Medicine|January 7, 2019
Heterozygous knockout insulin-like growth factor-1 receptor (IGF-1R) regulates mitochondrial functions and prevents colitis and colorectal cancerShu Qing Wang, Xiang Yu Yang, Shu Xiang Cui, et al.
Plos One|November 3, 2012
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptorsLi-Song Zhang, Shu-Qing Wang, Wei-Ren Xu, et al.
Plos One|December 6, 2011
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping methodXiao-Bo Li, Shu-Qing Wang, Wei-Ren Xu, et al.
Biochemical and Biophysical Research Communications|June 16, 2009
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virusShu-Qing Wang, Qi-Shi Du, Ri-Bo Huang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 9, 2014
Riparoside B and timosaponin J, two steroidal glycosides from Smilax riparia, resist to hyperuricemia based on URAT1 in hyperuricemic miceXiao-Hui Wu, Jun Zhang, Shu-Qing Wang, et al.
Drug Design, Development and Therapy|May 1, 2013
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformaticsLei Liu, Ying Ma, Run-Ling Wang, et al.
Oncotarget|July 25, 2016
KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathwayYan Liu, Shu-Qing Wang, Yue-Hong Long, et al.
Journal of Chemical Information and Modeling|April 7, 2012
Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor designQi-Shi Du, Jing Gao, Yu-Tuo Wei, et al.
Drug Design, Development and Therapy|November 26, 2014
Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazoneXue-Jiao Wang, Jun Zhang, Shu-Qing Wang, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Molecular Therapy. Nucleic Acids|March 13, 2019
Knockdown of IGF-1R Triggers Viral RNA Sensor MDA5- and RIG-I-Mediated Mitochondrial Apoptosis in Colonic Cancer CellsShu-Qing Wang, Xiang-Yu Yang, Xin-Feng Yu, et al.
Free Radical Biology & Medicine|January 7, 2019
Heterozygous knockout insulin-like growth factor-1 receptor (IGF-1R) regulates mitochondrial functions and prevents colitis and colorectal cancerShu Qing Wang, Xiang Yu Yang, Shu Xiang Cui, et al.
Plos One|November 3, 2012
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptorsLi-Song Zhang, Shu-Qing Wang, Wei-Ren Xu, et al.
Plos One|December 6, 2011
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping methodXiao-Bo Li, Shu-Qing Wang, Wei-Ren Xu, et al.
Biochemical and Biophysical Research Communications|June 16, 2009
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virusShu-Qing Wang, Qi-Shi Du, Ri-Bo Huang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 9, 2014
Riparoside B and timosaponin J, two steroidal glycosides from Smilax riparia, resist to hyperuricemia based on URAT1 in hyperuricemic miceXiao-Hui Wu, Jun Zhang, Shu-Qing Wang, et al.
Drug Design, Development and Therapy|May 1, 2013
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformaticsLei Liu, Ying Ma, Run-Ling Wang, et al.
Oncotarget|July 25, 2016
KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathwayYan Liu, Shu-Qing Wang, Yue-Hong Long, et al.
Journal of Chemical Information and Modeling|April 7, 2012
Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor designQi-Shi Du, Jing Gao, Yu-Tuo Wei, et al.
Drug Design, Development and Therapy|November 26, 2014
Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazoneXue-Jiao Wang, Jun Zhang, Shu-Qing Wang, et al.
Pageof 7